We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$804M
AUM Growth
+$62.4M
Cap. Flow
+$3.16M
Cap. Flow %
0.39%
Top 10 Hldgs %
27.6%
Holding
264
New
30
Increased
63
Reduced
144
Closed
15

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.84M
2
DELL icon
Dell
DELL
+$4.44M
3
MU icon
Micron Technology
MU
+$3.99M
4
IBM icon
IBM
IBM
+$2.52M
5
MDT icon
Medtronic
MDT
+$2.35M

Sector Composition

Rank Sector Weight
1 Technology 20.31%
2 Financials 11.52%
3 Healthcare 8.37%
4 Communication Services 6.65%
5 Industrials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
26
iShares Core S&P Mid-Cap ETF
IJH
$128B
$7.84M 0.98%
126,436
-11,875
-9% -$697K
DFAX icon
27
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.5B
$7.69M 0.96%
261,736
+87,791
+50% +$2.42M
MDT icon
28
Medtronic
MDT
$116B
$7.32M 0.91%
83,922
-27,723
-25% -$2.35M
XOM icon
29
ExxonMobil
XOM
$657B
$7.03M 0.87%
65,169
-10,528
-14% -$1.13M
TXN icon
30
Texas Instruments
TXN
$253B
$6.95M 0.86%
33,455
-8,089
-19% -$1.44M
GE icon
31
GE Aerospace
GE
$379B
$6.77M 0.84%
26,305
-910
-3% -$200K
REGN icon
32
Regeneron Pharmaceuticals
REGN
$82.2B
$6.75M 0.84%
12,861
+4,419
+52% +$2.47M
NEE icon
33
NextEra Energy
NEE
$179B
$6.75M 0.84%
97,243
+18,887
+24% +$1.31M
SYK icon
34
Stryker
SYK
$133B
$6.75M 0.84%
17,057
-677
-4% -$253K
SPYV icon
35
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
$6.64M 0.83%
126,822
-1,592
-1% -$79.6K
CME icon
36
CME Group
CME
$94.3B
$6.57M 0.82%
23,850
-403
-2% -$110K
NFLX icon
37
Netflix
NFLX
$309B
$6.57M 0.82%
49,050
-3,160
-6% -$357K
HD icon
38
Home Depot
HD
$342B
$6.24M 0.78%
17,021
-4,300
-20% -$1.56M
CSCO icon
39
Cisco
CSCO
$488B
$6.22M 0.77%
89,704
+12,463
+16% +$766K
CRH icon
40
CRH
CRH
$65.2B
$6.08M 0.76%
66,223
-1,198
-2% -$109K
EOG icon
41
EOG Resources
EOG
$75.1B
$6.01M 0.75%
50,226
-1,734
-3% -$198K
TJX icon
42
TJX Companies
TJX
$169B
$6.01M 0.75%
48,637
-3,582
-7% -$454K
JIRE icon
43
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.4B
$5.84M 0.73%
82,571
+22,437
+37% +$1.5M
GTLS
44
DELISTED
Chart Industries
GTLS
$5.81M 0.72%
35,268
-11,444
-24% -$1.68M
DFUS
45
Dimensional US Equity ETF
DFUS
$21.6B
$5.75M 0.72%
85,782
+15,053
+21% +$932K
BAC icon
46
Bank of America
BAC
$453B
$5.71M 0.71%
120,710
-5,290
-4% -$223K
AMD icon
47
Advanced Micro Devices
AMD
$788B
$5.71M 0.71%
+40,234
New +$4.38M
KO icon
48
Coca-Cola
KO
$373B
$5.6M 0.7%
79,167
+304
+0.4% +$21.7K
PG icon
49
Procter & Gamble
PG
$335B
$5.57M 0.69%
34,988
+8,166
+30% +$1.33M
WMT icon
50
Walmart Inc
WMT
$923B
$5.49M 0.68%
56,164
-2,050
-4% -$195K

Similar funds

Greenwood Capital Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Greenwood Capital Associates held 264 positions worth $804M, up 8.4% from $741M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Greenwood Capital Associates's Q2 2025 filing shows 30 new, 63 increased, 144 reduced and 15 closed positions. Its largest new stake was ASML: 6,795 shares worth $5.45M. The largest sale was Merck, an estimated $6.84M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Greenwood Capital Associates's largest Q2 2025 buy was ASML: 6,795 shares worth $5.45M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $14.3M increase.
  • Greenwood Capital Associates's biggest Q2 2025 reduction was IBM, cutting an estimated $2.52M.
  • Greenwood Capital Associates fully exited Merck in Q2 2025, selling an estimated $6.84M.
  • Greenwood Capital Associates's ten largest holdings make up 28% of its $804M portfolio in Q2 2025.
  • Greenwood Capital Associates opened 30 new positions and closed 15 in Q2 2025.
  • Greenwood Capital Associates's portfolio value rose 8.4% quarter-over-quarter to $804M.

Based on Greenwood Capital Associates's 13F filing for Q2 2025, filed 21 Jul 2025.